a public good project by the
Synthesis
Company
of California

© 2026

Monika Warmuth Metz | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Monika Warmuth Metz

Universitätsklinikum Würzburg(DE)

Research Areas

Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Neuroblastoma Research and Treatments

Most-Cited Works

→ A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma(2015)199 cited